Human Pathology
Volume 41, Issue 2 , Pages 190-198 , February 2010

Highly concordant coexpression of aromatase and estrogen receptor β in non–small cell lung cancer

  • Keiko Abe, MD, PhD

      Affiliations

    • Department of Pathology, Tohoku University Graduate School of Medicine, Sendai, Japan
    • Corresponding Author InformationCorresponding author.
    • ,
  • Yasuhiro Miki, PhD

      Affiliations

    • Department of Pathology, Tohoku University Graduate School of Medicine, Sendai, Japan
    • ,
  • Katsuhiko Ono, CT

      Affiliations

    • Department of Pathology, Tohoku University Graduate School of Medicine, Sendai, Japan
    • ,
  • Miki Mori, CT

      Affiliations

    • Department of Pathology, Tohoku University Graduate School of Medicine, Sendai, Japan
    • ,
  • Hideaki Kakinuma

      Affiliations

    • Department of Pathology, Tohoku University Graduate School of Medicine, Sendai, Japan
    • ,
  • Yuki Kou

      Affiliations

    • Department of Pathology, Tohoku University Graduate School of Medicine, Sendai, Japan
    • ,
  • Nobutaka Kudo

      Affiliations

    • Department of Pathology, Tohoku University Graduate School of Medicine, Sendai, Japan
    • ,
  • Masashi Koguchi

      Affiliations

    • Department of Pathology, Tohoku University Graduate School of Medicine, Sendai, Japan
    • ,
  • Hiromichi Niikawa, MD, PhD

      Affiliations

    • Department of Thoracic Surgery, Iwate Prefecture Central Hospital, Iwate, Japan
    • ,
  • Satoshi Suzuki, MD, PhD

      Affiliations

    • Department of Thoracic Surgery, Ishinomaki Redcross Hospital, Ishinomaki, Japan
    • ,
  • Dean B. Evans

      Affiliations

    • Novartis, Institutes for BioMedical Research Basel, Oncology Research, Basel, Switzerland
    • ,
  • Shunichi Sugawara, MD

      Affiliations

    • Department of Pulmonary Medicine, Sendai Kousei Hospital, Sendai, Japan
    • ,
  • Takashi Suzuki, MD, PhD

      Affiliations

    • Department of Pathology, Tohoku University Graduate School of Medicine, Sendai, Japan
    • ,
  • Hironobu Sasano, MD, PhD

      Affiliations

    • Department of Pathology, Tohoku University Graduate School of Medicine, Sendai, Japan

Received 14 May 2009 ,Revised 15 July 2009 ,Accepted 17 July 2009.

References 

  1. Yoshimi I, Ohshima A, Ajiki W, Tsukuma H, Sobue T. A comparison of trends in the incidence rate of lung cancer by histological type in the Osaka Cancer Registry, Japan and in the Surveillance, Epidemiology and End Results Program USA. Jpn J Clin Oncol. 2003;33:98–104
  2. Siegfried JM. Women and lung cancer: does oestrogen play a role?. Lancet Oncol. 2001;2:506–513
  3. Omoto Y, Kobayashi Y, Nishida K, et al. Expression, function, and clinical implications of the estrogen receptor β in human lung cancers. Biochem Biophysl Res Commun. 2001;285:340–347
  4. Dougherty SM, Mazhawidza W, Bohn AR, et al. Gender difference in the activity but not expression of estrogen receptors α and β in human lung adenocarcinoma cells. Endocr Relat Cancer. 2006;13:113–134
  5. Stabile LP, Davis AL, Gubish CT, et al. Human non–small cell lung tumors and cells derived from normal lung express both estrogen receptor α and β and show biological responses to estrogen. Cancer Res. 2002;62:2141–2150
  6. Hershberger PA, Vasquez AC, Kanterewicz B, Land S, Siegfried JM, Nichols M. Regulation of endogenous gene expression in human non-small cell lung cancer cells by estrogen receptor ligands. Cancer Res. 2005;65:1598–1605
  7. Mollerup S, Jorgensen K, Berge G, Haugen A. Expression of estrogen receptors α and β in human lung tissues and cell lines. Lung Cancer. 2002;37:153–159
  8. Thun MJ, Henley SJ, Burns D, Jemal A, Shanks TG, Calle EE. Lung cancer death rates in lifelong nonsmokers. J Natl Cancer Inst. 2006;98:691–699
  9. Weinberg OK, Marquez-Garban DC, Fishbein MC, et al. Aromatase inhibitors in human lung cancer therapy. Cancer Res. 2005;65:11287–11291
  10. Mah V, Seligson DB, Li A, et al. Aromatase expression predicts survival in women with early-stage non small cell lung cancer. Cancer Res. 2007;67:10484–10490
  11. Radzikowska E, Langfort R, Giedronowicz D. Estrogen and progesterone receptors in non small cell lung cancer patients. Ann Thorac Cardiovasc Surg. 2002;8:69–73
  12. Stabile LP, Lyker JS, Gubish CT, Zhang W, Grandis JR, Siegfried JM. Combined targeting of the estrogen receptor and the epidermal growth factor receptor in non-small cell lung cancer shows enhanced antiproliferative effects. Cancer Res. 2005;65:1459–1470
  13. Fasco MJ, Hurteau GJ, Spivack SD. Gender-dependent expression of alpha and beta estrogen receptors in human nontumor and tumor lung tissue. Mol Cell Endocrinol. 2002;188:125–140
  14. Enmark E, Pelto-Huikko M, Grandien K, et al. Human estrogen receptor beta-gene structure, chromosomal localization, and expression pattern. J Clin Endocrinol Metab. 1997;82:4258–4265
  15. Schwartz AG, Prysak GM, Murphy V, et al. Nuclear estrogen receptor β in lung cancer: expression and survival differences by sex. Clin Cancer Res. 2005;11:7280–7287
  16. Wu CT, Chang YL, Shih JY, Lee YC. The significance of estrogen receptor beta in 301 surgically treated non-small cell lung cancers. J Thorac Cardiovasc Surg. 2005;130:979–986
  17. Kawai H, Ishii A, Washiya K, et al. Estrogen receptor alpha and beta are prognostic factors in non-small cell lung cancer. Clin Cancer Res. 2005;11:5084–5089
  18. Skov BG, Fischer BM, Pappot H. Oestrogen receptor β over expression in males with non-small cell lung cancer is associated with better survival. Lung Cancer. 2008;59:88–94
  19. Ishibashi H, Suzuki T, Suzuki S, et al. Progesterone receptor in non-small cell lung cancer—a potent prognostic factor and possible target for endocrine therapy. Cancer Res. 2005;65:6450–6458
  20. Allred DC, Harvey JM, Berardo M, Clark GM. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol. 1998;11:155–168
  21. Suzuki T, Miki Y, Moriya T, et al. 5Alpha-reductase type 1 and aromatase in breast carcinoma as regulators of in situ androgen production. Int J Cancer. 2007;120:285–891
  22. Sasano H, Anderson TJ, Silverberg SG, et al. The validation of new aromatase monoclonal antibodies for immunohistochemistry—a correlation with biochemical activities in 46 cases of breast cancer. J Steroid Biochem Mol Biol. 2005;95:35–39
  23. Niikawa H, Suzuki T, Miki Y, et al. Intratumoral estrogens and estrogen receptors in human non-small cell lung carcinoma. Clin Cancer Res. 2008;14:4417–4426
  24. Iwao K, Miyoshi Y, Egawa C, Ikeda N, Noguchi S. Quantitative analysis of estrogen receptor-β mRNA and its variants in human breast cancers. Int J Cancer. 2000;88:733–736
  25. Hershberger PA, Stabile LP, Kanterewicz B, et al. Estrogen receptor beta (ERbeta) subtype-specific ligands increase transcription, p44/p42 mitogen activated protein kinase (MAPK) activation and growth in human non-small cell lung cancer cells. J Steroid Biochem Mol Biol. 2009;116:102–109
  26. Mandusic V, Nikolic-Vukosaviljevic D, Tanic N, et al. Expression of estrogen receptor beta wt isoform (ER beta 1) and ERbetaDelta5 splice variant mRNAs in sporadic breast cancer. J Cancer Res Clin Oncol. 2007;133:571–579
  27. Dannenmann C, Shabani N, Friese K, Jeschke U, Mylonas I, Bruning A. The metastasis-associated gene MTA1 is upregulated in advanced ovarian cancer, represses ERβ, and enhances expression of oncogenic cytokine GRO. Cancer Biol Ther. 2008;7:1460–1467
  28. Horii R, Akiyama F, Ito Y, Iwase T. Assessment of hormone receptor status in breast cancer. Pathol Int. 2007;57:784–790
  29. Patrone C, Cassel TN, Petterson K, et al. Regulation of postnatal lung development and homeostasis by estrogen receptor β. Mol Cell Biol. 2003;23:8542–8552
  30. Yokota J, Kohno T. Molecular footprints of human lung cancer progression. Cancer Sci. 2004;95:197–204
  31. Skliris GP, Munot K, Bell SM, et al. Reduced expression of oestrogen receptor β in invasive breast cancer and its re-expression using DNA methyl transferase inhibitors in a cell line model. J Pathol. 2003;201:213–220
  32. Zhao C, Lam EW, Sunters A Enmark E, et al. Expression of estrogen receptor β isoforms in normal breast epithelial cells and breast cancer: regulation by methylation. Oncogene. 2003;22:7600–7606
  33. Park BW, Kim KS, Heo MK, et al. Expression of estrogen receptor-β in normal mammary and tumor tissues: is it protective in breast carcinogenesis?. Breast Cancer Res Treat. 2003;80:79–85
  34. Jarvinen TA, Pelto-Huikko M, Holli K, Isola J. Estrogen receptor β is coexpressed with ERα and PR and associated with nodal status, grade, and proliferation rate in breast cancer. Am J Pathol. 2000;156:29–35
  35. Walker RA, Martin CV. The aged breast. J Pathol. 2007;211:232–240

☆ This work was supported, in part, by a grant-in-aid for Scientific Research from the Ministry of Health and Welfare, and a grant-in-aid from the Ministry of Education, Science and Culture.

PII: S0046-8177(09)00260-3

doi: 10.1016/j.humpath.2009.07.010

Human Pathology
Volume 41, Issue 2 , Pages 190-198 , February 2010

Article Tools

* Image Usage & Resolution